Pharvaris (PHVS) Receivables (2019 - 2026)
Pharvaris (PHVS) posted Receivables of $1.1 million for Q1 2026, up 75.16% on a QoQ basis from $648068.4 in Q4 2025, and up 85.07% year-over-year from $613377.0 in Q1 2025.
Pharvaris (PHVS) Receivables (2019 - 2026) Analysis & Trends
Pharvaris' Receivables history runs 8 years deep, the most recent figure standing at $1.1 million for Q1 2026.
- Quarterly Receivables rose 85.07% year-over-year to $1.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.1 million (up 85.07% YoY) and the FY2025 annual result came in at $5.1 million, up 61.34% from the prior year.
- Receivables was $1.1 million for Q1 2026 at Pharvaris, up from $648068.4 in the prior quarter.
- Across five years, Receivables topped out at $1.1 million in Q1 2026 and bottomed at $336205.7 in Q3 2023.
- A 5-year average of $539213.5 and a median of $472442.4 in 2023 frame the typical range for Receivables.
- Annual changes were most pronounced in 2022 — Receivables slumped 58.74% — and 2024, when it soared 110.82%.
- Pharvaris' Receivables stood at $390212.0 in 2022, then rose by 16.77% to $455645.5 in 2023, then advanced by 7.37% to $489239.3 in 2024, then surged by 32.46% to $648068.4 in 2025, then surged by 75.16% to $1.1 million in 2026.
- Business Quant data shows PHVS's Receivables at $1.1 million in Q1 2026, $648068.4 in Q4 2025, and $601795.0 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | 4.97 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 938.02 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 2.00 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 5.73 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Pharvaris | 2.22 Bn | 1.94 Bn | - | 1.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.14 Mn |
| Dec 31, 2025 | 648,068.42 |
| Jun 30, 2025 | 601,795.05 |
| Mar 31, 2025 | 613,376.96 |
| Dec 31, 2024 | 489,239.31 |
| Sep 30, 2024 | 708,782.08 |
| Jun 30, 2024 | 554,924.48 |
| Mar 31, 2024 | 394,426.45 |
| Dec 31, 2023 | 455,645.49 |
| Sep 30, 2023 | 336,205.73 |
| Jun 30, 2023 | 364,026.34 |
| Mar 31, 2023 | 422,984.69 |
| Dec 31, 2022 | 390,211.97 |
| Sep 30, 2022 | 407,499.11 |
| Jun 30, 2022 | 354,185.99 |
| Mar 31, 2022 | 750,859.65 |
| Dec 31, 2021 | 800,870.04 |
| Sep 30, 2021 | 745,742.39 |
| Jun 30, 2021 | 858,362.53 |
| Mar 31, 2021 | 652,954.91 |